All Posts
RCT: Bortezomib in newly diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
18 Mar, 2022 | 07:50h | UTCChildren’s Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma – Journal of Clinical Oncology (link to abstract – $ for full-text)
M-A: Duration of postpartum magnesium sulphate for the prevention of eclampsia.
18 Mar, 2022 | 07:38h | UTC
Systematic Review: Behavioral approaches to recruitment and retention in clinical trials.
18 Mar, 2022 | 07:40h | UTCRelated:
Perspective: How Can We Keep Participants in Clinical Trials Involved
RCT: Short-term radiotherapy plus chemotherapy vs. long-term chemoradiotherapy in locally advanced rectal cancer.
18 Mar, 2022 | 07:39h | UTC
M-A: Comparative efficacy and safety of pharmacological interventions to prevent Mother-to-Child transmission of hepatitis B virus.
18 Mar, 2022 | 07:37h | UTC
State of the Art Review: Recent advances in the diagnosis and management of cluster headache.
17 Mar, 2022 | 09:21h | UTCRecent advances in the diagnosis and management of cluster headache – The BMJ
2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play.
17 Mar, 2022 | 09:26h | UTCCommentaries:
ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology
ACC Releases Guidance on CV Issues With COVID-19 – TCTMD
Key Points: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19
Related:
Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.
COVID-19 infections increase risk of heart conditions up to a year later, study finds.
Commentary on Twitter (thread – click for more)
Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem
— American College of Cardiology (@ACCinTouch) March 16, 2022
Among health care workers, a fourth dose vaccine effectiveness against any SARS-CoV-2 Omicron variant infection was 30% for the Pfizer–BioNTech and 11% for the Moderna.
17 Mar, 2022 | 09:12h | UTCEfficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine
Related: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Treatments for moderate to severe COVID-19: Cochrane evidence.
17 Mar, 2022 | 09:19h | UTCTreatments for moderate to severe COVID-19: Cochrane evidence – Evidently Cochrane
Effectiveness of the Sputnik V, AstraZeneca, and Sinopharm vaccines for the risk of infection and death due to COVID-19 in people older than 60 years in Argentina.
17 Mar, 2022 | 09:10h | UTCCommentary: Evaluating COVID-19 vaccines in the real world – The Lancet
Treatments for mild COVID-19: Cochrane evidence.
17 Mar, 2022 | 09:17h | UTCTreatments for mild COVID-19: Cochrane evidence – Cochrane Library
[News release – not published yet] Empagliflozin phase III EMPA-KIDNEY trial will stop early due to evidence of efficacy in people with chronic kidney disease.
17 Mar, 2022 | 09:07h | UTC
Commentary on Twitter
Details of the design & pt characteristics now published:
6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9— Martin Landray (@MartinLandray) March 16, 2022
Malignant Hypertension: Current perspectives and challenges.
17 Mar, 2022 | 09:03h | UTC
EULAR recommendations regarding lifestyle behaviors and work participation to prevent progression of rheumatic and musculoskeletal diseases.
17 Mar, 2022 | 08:58h | UTC
Commentary on Twitter
🚨 New very patient-centered #EULAR recommendations regarding lifestyle modifications published🚨
Areas covered include:
🏃♀️ 🏊 🚴♂️ — Excercise
🥗 🥙 🍝 — Diet
⚖️ 😱 — Weight
🍻 🍷🥃 — Alcohol
🚬 🚭 — Smoking
👨💼 👷♀️ 🏢 🏗️ — Work https://t.co/7ZroM2j98I— Annals of the Rheumatic Diseases (@eular_ARD) March 10, 2022
Denmark proposes ban on selling cigarettes to people born after 2010.
17 Mar, 2022 | 09:04h | UTCDenmark proposes ban on selling cigarettes to people born after 2010 – euronews
Commentary on Twitter
Happy to see this bold move by #Denmark to ban the sale of cigarettes to people born after 2010, and that the majority of 🇩🇰 people support this #NoTobacco decision. @WHO looks forward to working together to create ‘tobacco-free generations’ from now on.https://t.co/6BF0OeakrI
— Tedros Adhanom Ghebreyesus (@DrTedros) March 16, 2022
Guideline: Fall prevention in hospitals and nursing homes.
17 Mar, 2022 | 08:55h | UTC
Open-Label, multicenter study of Flecainide Acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm.
17 Mar, 2022 | 09:01h | UTC
Commentary on Twitter
Inhalation of flecainide simply converts many episodes of recent onset atrial fibrillation #AHAJournals #HeartMonthhttps://t.co/vNXx4fKy2u pic.twitter.com/UNGA9DX3qM
— CircEP (@CirculationEP) February 25, 2022
Position Paper: Multi-modality imaging assessment of native valvular regurgitation.
17 Mar, 2022 | 08:49h | UTC
Management of the secondary spontaneous pneumothorax: current guidance, controversies, and recent advances.
17 Mar, 2022 | 08:51h | UTC
Summary: German evidence-based guidelines on focal therapy in localized prostate cancer.
17 Mar, 2022 | 08:47h | UTC
Expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.
17 Mar, 2022 | 08:45h | UTC
RCT: Effect of early vs. late supplemental parenteral nutrition in patients undergoing abdominal surgery.
17 Mar, 2022 | 08:43h | UTCInvited Commentary: Early Postoperative Supplementary Parenteral Nutrition – JAMA Surgery
Author Interview: Supplemental Parenteral Nutrition in Patients Undergoing Abdominal Surgery
Commentary on Twitter
Randomized clinical trial found supplemental parenteral nutrition in combination with enteral nutrition could significantly reduce the incidence of nosocomial infections in patients undergoing abdominal surgery. https://t.co/Agbf9TKPfX
— JAMA Surgery (@JAMASurgery) March 16, 2022
Cohort Study: Association between long-term exposure to air pollution and immune-mediated diseases.
17 Mar, 2022 | 08:40h | UTCNews Release: Long term exposure to air pollution linked to heightened autoimmune disease risk – BMJ Newsroom
Commentaries:
Air pollution linked to higher risk of autoimmune diseases – The Guardian
Breathing Dirty Air Could Raise Your Odds for Rheumatoid Arthritis – HealthDay
At-a-glance PICO summaries are now available with Cochrane Abstracts.
17 Mar, 2022 | 08:36h | UTC
Commentary on Twitter
New @CochraneLibrary feature! #PICO terms will now display on Cochrane review pages, helping you to find the most relevant Cochrane evidence to answer your research or clinical question! https://t.co/KkRaXJXpCc pic.twitter.com/LHCPgyPiE6
— The Cochrane Library (@CochraneLibrary) March 16, 2022
Review: Mechanistic and clinical overview of cardiovascular toxicity with BRAF and MEK inhibitors.
17 Mar, 2022 | 08:34h | UTC
Commentary on Twitter
New #JACCCardioOnc issue is out!
BRAF/MEK inhibitors are associated w/ adverse CV effects including HTN, LV dysfunction, #VTE, atrial arrhythmias, & QT prolongation. Learn more in this state-of-the-art review: https://t.co/2r9L90DTmL#CardioOnc #CardioTwitter #Hypertension pic.twitter.com/Dz8i0sfBTU
— JACC Journals (@JACCJournals) March 15, 2022